Reviews for Primary Care - Fall 2007 - (Page 29)

Chronic Constipation and Functional Bowel Disorders 55. 56. 57. 58. 59. 60. Camilleri M, Bharucha AE, Ueno R, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006;290:G942-G947. Johanson JF, Gargano MA, Holland PC, Patchen ML. Initial and sustained effects of lubiprostone, a chloride channel-2 (ClC-2) activator for the treatment of constipation: data from a 4-week phase III study [abstract]. Am J Gastroenterol. 2005;100(suppl 9):S324. Johanson JF, Gargano MA, Holland PC, et al. Phase III safety and efficacy of RU-0211, a chloride channel activator, for the treatment of constipation [abstract]. Gastroenterology. 2003;124 (4 suppl 1):A-48. Ueno R, Wahle A, Panas R, et al. Evaluation of safety and efficacy in a twelve-month study of lubiprostone for the treatment of chronic idiopathic constipation [abstract]. Am J Gastroenterol. 2006;101(suppl 2):S491. Crowell MD, Harris LA, DiBlaise JK, Olden KW. Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation. Curr Opin Investig Drugs. 2007; 8:66-70. Sucampo Pharmaceuticals submits supplemental new drug application for lubiprostone to treat irritable bowel syndrome with constipation. Sucampo Pharmaceuticals Web site. http:// investor.sucampo.com/phoenix.zhtml?c=201197 &p=irol-newsArticle&ID=1032666&highlight=. Published July 12, 2007. Accessed August 9, 2007. 61. 62. 63. 64. 65. 66. 67. Drossman DA, Chey W, Panas R, et al. Lubiprostone significantly improves symptom relief rates in adults with irritable bowel syndrome and constipation (IBS-C): data from two twelve-week, randomized, placebo-controlled, double-blind trials [abstract]. Gastroenterology. 2007;132: 2586-2587. Heymen S, Scarlett Y, Jones K, et al. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum. 2007;50:428-441. Chiarioni G, Whitehead WE, Pezza V, et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130:657-664. Johanson JF, Panas R, Holland PC, Ueno R. A dose-ranging, double-blind, placebo-controlled study of lubiprostone in subjects with irritable bowel syndrome and constipation (c-IBS) [abstract]. Gastroenterology. 2006;130(4 suppl 2): A-25. Prather CM. Pregnancy-related constipation. Curr Gastroenterol Rep. 2004;6:402-404. Becker D, Compagnone D, Lu L. Lactulose in the treatment of constipation in pregnant Chinese women: a double-blind, randomized, placebocontrolled, multicenter study [abstract]. Gastroenterology. 2006;130(4 suppl 2):A-599-A-600. Engelke K, Harris S, Roerig B, Ueno R. Effect of lubiprostone, a novel type-2 chloride channel (Clc-2) activator, in pregnant rhesus monkeys [abstract]. Gastroenterology. 2007;132(4 suppl 2): A-534. 68. DiPalma JA, Cleveland MV, McGowan J, Herrera JL. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther. 2007;25:703708. 69. Ueno R, Joswick TR, Wahle A, et al. Efficacy and safety of lubiprostone for the treatment of chronic constipation in elderly vs non-elderly subjects [abstract]. Gastroenterology. 2006;130(4 suppl 2):A-189. 70. Ueno R, Joswick TR, Wahle A, et al. Efficacy and safety of lubiprostone for the treatment of chronic idiopathic constipation in elderly patients. Paper presented at: 71st Annual Scientific Meeting and Postgraduate Course of the American College of Gastroenterology; October 20-25, 2006; Las Vegas, NV. 71. Rivera E, Wahle A, Joswick TR, Ueno R. Lubiprostone, a novel type-2 chloride channel (ClC-2) activator, does not affect serum electrolyte balance in elderly and non-elderly patients with chronic idiopathic constipation [abstract]. Gastroenterology. 2007;132(4 suppl 2): A-191. 72. Corman ML. Colon and Rectal Surgery. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. 73. Zutshi M, Hull TL, Trzcinski R, et al. Surgery for slow transit constipation: are we helping patients? Int J Colorectal Dis. 2007;22:265-269. 74. Treatment of pelvic floor dysfunction. Mayo Clinic Web site. http://www.mayoclinic.org/ constipation/treatment-pelvic-floor-dysfunction. html. Accessed August 9, 2007. To receive credit for this CME/CPE/CE activity, please visit http://www.totalmeded.com/ddwmonograph. VOL. 1 NO. 1 2007 REVIEWS FOR PRIMARY CARE 29 http://investor.sucampo.com/phoenix.zhtml?c=201197&p=irol-newsArticle&ID=1032666&highlight= http://investor.sucampo.com/phoenix.zhtml?c=201197&p=irol-newsArticle&ID=1032666&highlight= http://www.mayoclinic.org/constipation/treatment-pelvic-floor-dysfunction.html http://investor.sucampo.com/phoenix.zhtml?c=201197&p=irol-newsArticle&ID=1032666&highlight= http://www.mayoclinic.org/constipation/treatment-pelvic-floor-dysfunction.html http://www.mayoclinic.org/constipation/treatment-pelvic-floor-dysfunction.html http://www.totalmeded.com/ddwmonograph Table of Contents for the Digital Edition of Reviews for Primary Care - Fall 2007Reviews for Primary Care - Fall 2007Alpha Blockers for the Treatment of Benign Prostatic HyperplasiaFresh Perspectives in Chronic Constipation and Other Functional Bowel DisordersInhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy?Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological FunctionGastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERDHuman Papillomavirus (HPV), HPV-Related Disease, and the HPV VaccineReviews for Primary Care - Fall 2007Reviews for Primary Care - Fall 2007 - Reviews for Primary Care - Fall 2007 (Page Cover)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 1)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 2)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 3)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 4)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 5)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 6)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 7)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 8)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 9)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 10)Reviews for Primary Care - Fall 2007 - Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia (Page 11)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 12)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 13)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 14)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 15)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 16)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 17)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 18)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 19)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 20)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 21)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 22)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 23)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 24)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 25)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 26)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 27)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 28)Reviews for Primary Care - Fall 2007 - Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders (Page 29)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 30)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 31)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 32)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 33)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 34)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 35)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 36)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 37)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 38)Reviews for Primary Care - Fall 2007 - Inhibiting the Renin-Angiotensin System to Prevent Cardiovascular Diseases: Do We Need a More Comprehensive Strategy? (Page 39)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 40)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 41)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 42)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 43)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 44)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 45)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 46)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 47)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 48)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 49)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 50)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 51)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 52)Reviews for Primary Care - Fall 2007 - Clinical Neurology of Insomnia in Neurodegenerative and Other Disorders of Neurological Function (Page 53)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 54)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 55)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 56)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 57)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 58)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 59)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 60)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 61)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 62)Reviews for Primary Care - Fall 2007 - Gastroesophageal Reflux Disease Symptoms on Antisecretory Therapy: Acid, Non-Acid, or No GERD (Page 63)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 64)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 65)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 66)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 67)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 68)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 69)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 70)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 71)Reviews for Primary Care - Fall 2007 - Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine (Page 72)http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.